Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial.

Ghani, Sundus A; Burney, Sheeba; Muzaffar, Fiza; Naseem, Laiba; Ul Hussain, Hassan; Rehan, Syeda T; Mumtaz, Hassan

Ghani, Sundus A; Burney, Sheeba; Muzaffar, Fiza; Naseem, Laiba; Ul Hussain, Hassan; Rehan, Syeda T; Mumtaz, Hassan.

Afiliación

Ghani SA; Dow University of Health Sciences, Karachi.
Burney S; Dow University of Health Sciences, Karachi.
Muzaffar F; Dow University of Health Sciences, Karachi.
Naseem L; Dow University of Health Sciences, Karachi.
Ul Hussain H; Dow University of Health Sciences, Karachi.
Rehan ST; Dow University of Health Sciences, Karachi.
Mumtaz H; Health services Academy, Islamabad, Pakistan.

Int J Surg ; 109(2): 83-84, 2023 02 01.

Article en En | MEDLINE | ID: mdl-36799810

Asunto(s)

Hiperoxaluria Primaria; Hiperoxaluria; Humanos; Hiperoxaluria Primaria/diagnóstico; Hiperoxaluria Primaria/terapia; ARN Interferente Pequeño

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperoxaluria / Hiperoxaluria Primaria Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Int J Surg Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google